Understanding the Female Sexual Function Index (FSFI): A Clinically Validated Tool for Assessing Women’s Sexual Health
The Female Sexual Function Index (FSFI) is a scientifically validated questionnaire that helps assess key aspects of sexual function in women. Widely recognized in both research and clinical settings, the FSFI has become a standard tool for identifying potential sexual dysfunction and guiding treatment decisions.
What is the FSFI?
The FSFI is a 19-item self-report questionnaire developed to measure sexual function in women over the past four weeks. It evaluates six specific domains:
- Desire
- Arousal
- Lubrication
- Orgasm
- Satisfaction
- Pain
Each domain represents a critical component of sexual response and is measured through targeted questions. Responses are rated on a Likert scale, which allows healthcare providers and researchers to quantify sexual health in a meaningful and reproducible way.
Domain Structure and Scoring
The FSFI’s scoring system is both structured and evidence-based. Each domain is scored separately by summing the item responses and applying a multiplier to normalize the score (so each domain contributes a maximum of 6 points):
- Desire (Q1–2): Score range 1–5, domain score = (Q1 + Q2) × 0.6
- Arousal (Q3–6): Score range 0–5, domain score = (Q3 + Q4 + Q5 + Q6) × 0.3
- Lubrication (Q7–10): Score range 0–5, domain score = (Q7 + Q8 + Q9 + Q10) × 0.3
- Orgasm (Q11–13): Score range 0–5, domain score = (Q11 + Q12 + Q13) × 0.4
- Satisfaction (Q14–16): Score range 0 (or 1)–5, domain score = (Q14 + Q15 + Q16) × 0.4
- Pain (Q17–19): Score range 0–5, domain score = (Q17 + Q18 + Q19) × 0.4
Total FSFI Score: Sum of all six domain scores, ranging from 2.0 to 36.0. Higher scores indicate better sexual function.
Evidence-Based Validation
The FSFI was originally developed and validated in 2000 and has since undergone extensive testing for reliability and accuracy. It is widely cited in peer-reviewed medical literature and is recommended by leading health organizations such as the American College of Obstetricians and Gynecologists (ACOG) as a clinically validated tool for evaluating female sexual dysfunction.
For reference, see:
The Clinical Cutoff: 26.55
Based on a cross-validation study, researchers established that a total FSFI score of ≤26.55 is the optimal cutoff point for distinguishing between women with and without sexual dysfunction. This threshold has been validated for use in both clinical and research environments and provides a reliable screening benchmark.
Read the Wiegel et al. cross-validation study
While not a standalone diagnostic tool, the FSFI—and the 26.55 cutoff—serve as effective indicators to prompt further evaluation or intervention.
Conclusion
The FSFI is an invaluable, evidence-based instrument in women’s sexual health research and clinical care. Its structured scoring system, comprehensive domain coverage, and scientifically validated cutoff make it a trusted measure for identifying and addressing female sexual dysfunction.
Whether used in a clinical setting or as part of a digital health solution, the FSFI offers a reliable and meaningful assessment of sexual function that can empower better outcomes for women.
Disclaimer: The FSFI is a clinical tool and should be interpreted by healthcare professionals within the context of a complete medical evaluation.
